MX2018013477A - Acidos carboxilicos para tratar/prevenir una enfermedad de la piel. - Google Patents
Acidos carboxilicos para tratar/prevenir una enfermedad de la piel.Info
- Publication number
- MX2018013477A MX2018013477A MX2018013477A MX2018013477A MX2018013477A MX 2018013477 A MX2018013477 A MX 2018013477A MX 2018013477 A MX2018013477 A MX 2018013477A MX 2018013477 A MX2018013477 A MX 2018013477A MX 2018013477 A MX2018013477 A MX 2018013477A
- Authority
- MX
- Mexico
- Prior art keywords
- skin
- treating
- preventing
- carboxylic acid
- skin disease
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Otolaryngology (AREA)
- Emergency Medicine (AREA)
- Birds (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invención se refiere a una composición farmacéutica que comprende un ácido carboxílico o una sal farmacéuticamente aceptable del mismo como ingrediente activo para usar en el tratamiento y/o prevención de una enfermedad de la piel. La invención también se refiere a un método para tratar y/o prevenir una enfermedad de la piel en un paciente, el método comprende administrar una cantidad efectiva de un ácido carboxílico o una sal farmacéuticamente aceptable del mismo a un paciente que lo necesita. Además, la invención proporciona usos cosméticos de una composición que comprende un ácido carboxílico o una sal del mismo para reducir el enrojecimiento de la piel, lesiones de la piel, arrugas, impurezas o irregularidades de la piel. Además, la presente invención se refiere a una composición farmacéutica que comprende como ingrediente activo un ácido carboxílico o una sal farmacéutica del mismo para usar para mejorar la función de barrera cutánea, donde la composición farmacéutica se administra a un lactante y un método para tratar y/o prevenir una enfermedad de la piel de un paciente, el método comprende administrar una cantidad efectiva de un ácido carboxílico o una sal farmacéuticamente aceptable del mismo a un paciente que lo necesita.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16169883 | 2016-05-17 | ||
| PCT/EP2017/061826 WO2017198701A1 (en) | 2016-05-17 | 2017-05-17 | Carboxylic acids for treating/preventing a skin disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2018013477A true MX2018013477A (es) | 2019-02-28 |
Family
ID=56014857
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018013477A MX2018013477A (es) | 2016-05-17 | 2017-05-17 | Acidos carboxilicos para tratar/prevenir una enfermedad de la piel. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20200360317A1 (es) |
| EP (1) | EP3458042A1 (es) |
| JP (1) | JP2019516796A (es) |
| KR (1) | KR20190008235A (es) |
| CN (1) | CN109152753A (es) |
| AU (1) | AU2017266725A1 (es) |
| BR (1) | BR112018072164A2 (es) |
| CA (1) | CA3020562A1 (es) |
| CL (1) | CL2018003268A1 (es) |
| MX (1) | MX2018013477A (es) |
| RU (1) | RU2018143562A (es) |
| SG (1) | SG11201807911TA (es) |
| WO (1) | WO2017198701A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022020332A1 (en) | 2020-07-21 | 2022-01-27 | Chembeau LLC | Diester cosmetic formulations and uses thereof |
| WO2023170597A1 (en) * | 2022-03-08 | 2023-09-14 | Sila S.P.A. | Topical composition for treating injuries or cutaneous inflammatory states or proctological pathologies |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1163107A (zh) * | 1996-04-19 | 1997-10-29 | 迟经惠 | 顽癣治疗液 |
| EP1041990B1 (en) * | 1997-12-23 | 2006-06-28 | Schering Corporation | Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine |
| DE10032964B4 (de) * | 2000-07-06 | 2017-10-12 | Beiersdorf Ag | Verwendung von Kreatin in kosmetischen oder dermatologischen Zubereitungen |
| US20030064081A1 (en) * | 2001-10-01 | 2003-04-03 | Morgan William H. | Topical anti-pruritic composition |
| JPWO2008096730A1 (ja) * | 2007-02-09 | 2010-05-20 | 国立大学法人名古屋大学 | 抗炎症剤及びその用途 |
| CN101380317B (zh) * | 2007-09-07 | 2010-12-08 | 英属开曼群岛商安盛开发药物股份有限公司 | 减缓搔痒症的药学组合物 |
| WO2012131069A1 (en) * | 2011-03-31 | 2012-10-04 | Proponent Biotech Gmbh | Short chain fatty acids and their derivatives for use in treatment immunogenic disorders |
| EP2903608B1 (en) * | 2012-10-03 | 2019-08-28 | Proponent Biotech GmbH | Pharmaceutical composition comprising propionic acid for use in the treatment of viral infections |
-
2017
- 2017-05-17 RU RU2018143562A patent/RU2018143562A/ru not_active Application Discontinuation
- 2017-05-17 CN CN201780029987.1A patent/CN109152753A/zh active Pending
- 2017-05-17 BR BR112018072164-6A patent/BR112018072164A2/pt not_active Application Discontinuation
- 2017-05-17 EP EP17723138.8A patent/EP3458042A1/en not_active Withdrawn
- 2017-05-17 JP JP2019513480A patent/JP2019516796A/ja active Pending
- 2017-05-17 MX MX2018013477A patent/MX2018013477A/es unknown
- 2017-05-17 KR KR1020187033154A patent/KR20190008235A/ko unknown
- 2017-05-17 WO PCT/EP2017/061826 patent/WO2017198701A1/en active Application Filing
- 2017-05-17 SG SG11201807911TA patent/SG11201807911TA/en unknown
- 2017-05-17 CA CA3020562A patent/CA3020562A1/en not_active Abandoned
- 2017-05-17 AU AU2017266725A patent/AU2017266725A1/en not_active Abandoned
- 2017-05-17 US US16/097,720 patent/US20200360317A1/en not_active Abandoned
-
2018
- 2018-11-16 CL CL2018003268A patent/CL2018003268A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN109152753A (zh) | 2019-01-04 |
| RU2018143562A (ru) | 2020-06-17 |
| EP3458042A1 (en) | 2019-03-27 |
| AU2017266725A1 (en) | 2018-10-04 |
| CL2018003268A1 (es) | 2019-02-22 |
| SG11201807911TA (en) | 2018-10-30 |
| BR112018072164A2 (pt) | 2019-02-12 |
| CA3020562A1 (en) | 2017-11-23 |
| KR20190008235A (ko) | 2019-01-23 |
| WO2017198701A1 (en) | 2017-11-23 |
| JP2019516796A (ja) | 2019-06-20 |
| US20200360317A1 (en) | 2020-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12017502092A1 (en) | Topical pharmaceutical compositions | |
| CA2883751A1 (en) | Methods of treating alzheimer's disease and pharmaceutical compositions thereof | |
| MX2019012884A (es) | Terapia de combinacion. | |
| EA201270221A1 (ru) | Лечение болезни крона с применением лаквинимода | |
| NZ714963A (en) | Compositions and methods for treating anemia | |
| EA201590166A1 (ru) | Комбинированная терапия для лечения рассеянного склероза | |
| JP2014139220A5 (es) | ||
| JP2016517431A5 (es) | ||
| MX344329B (es) | Formulación de una combinación de dronedarona y ranolazina para la manufactura de un medicamento para tratar fibrilación atrial. | |
| WO2015085143A3 (en) | Therapeutic agents for skin diseases and conditions | |
| MX2012000275A (es) | Antagonista de bomba de acido para el tratamiento de enfermedades involucradas en la motilidad gastrointestinal anormal. | |
| PE20150161A1 (es) | Uso de laquinimod de dosis alta para el tratamiento de esclerosis multiple | |
| MY163235A (en) | Pharmaceutical preparation containing pyridylaminoacetic acid compound | |
| RU2014150942A (ru) | Лечение побочных эффектов в виде моторных и двигательных расстройств, связанных с лечением болезни паркинсона | |
| JP2017533972A5 (es) | ||
| WO2010107251A2 (ko) | 파카스트리사민을 유효성분으로 함유하는 과증식성 피부질환과 악성흑생종의 예방 또는 치료용 약학적 조성물 | |
| MX2018013477A (es) | Acidos carboxilicos para tratar/prevenir una enfermedad de la piel. | |
| MX2016016400A (es) | Formulaciones de oximetazolina estabilizadas y sus usos. | |
| SG10201908690WA (en) | Novel method of use and compositions | |
| MX2020000164A (es) | Formulaciones de isotretinoína para la mucosa oral y métodos para usar las mismas. | |
| NZ754328A (en) | Marker for acid sphingomyelinase disorders and uses thereof | |
| MX2018013474A (es) | Acidos carboxilicos para aplicacion en la primera infancia. | |
| MX2016008546A (es) | Reduccion de queloides utilizando alantoina topica. | |
| MX2021014093A (es) | Composiciones y metodos para tratar el mal de alzheimer y la enfermedad de parkinson. | |
| SG11201903834XA (en) | Medical skin external preparation |